SG10201605314TA - Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation - Google Patents

Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation

Info

Publication number
SG10201605314TA
SG10201605314TA SG10201605314TA SG10201605314TA SG10201605314TA SG 10201605314T A SG10201605314T A SG 10201605314TA SG 10201605314T A SG10201605314T A SG 10201605314TA SG 10201605314T A SG10201605314T A SG 10201605314TA SG 10201605314T A SG10201605314T A SG 10201605314TA
Authority
SG
Singapore
Prior art keywords
premature ejaculation
treating premature
pharmaceutical composition
treating
ejaculation
Prior art date
Application number
SG10201605314TA
Inventor
Hong-Ryeol Jeon
Do-Woo Kwon
Bong-Sang Lee
Seong-Shin Kwak
Sun-Ahe Lee
Hyun-Jung Park
Jeong-Hwa Yoo
Original Assignee
Ctc Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ctc Bio Inc filed Critical Ctc Bio Inc
Publication of SG10201605314TA publication Critical patent/SG10201605314TA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG10201605314TA 2011-06-28 2012-06-28 Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation SG10201605314TA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20110062620 2011-06-28

Publications (1)

Publication Number Publication Date
SG10201605314TA true SG10201605314TA (en) 2016-08-30

Family

ID=47424682

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10201605314TA SG10201605314TA (en) 2011-06-28 2012-06-28 Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation

Country Status (20)

Country Link
US (2) US20140200210A1 (en)
EP (2) EP3323416B1 (en)
JP (1) JP6042886B2 (en)
KR (1) KR101978459B1 (en)
CN (1) CN103635194B (en)
AU (1) AU2012276476B2 (en)
BR (1) BR112013033475A2 (en)
CA (1) CA2840521C (en)
EA (1) EA029932B1 (en)
ES (1) ES2668943T3 (en)
HK (1) HK1193050A1 (en)
IL (1) IL230174A (en)
MA (1) MA35610B1 (en)
MX (1) MX367663B (en)
MY (1) MY167609A (en)
SG (1) SG10201605314TA (en)
TN (1) TN2013000526A1 (en)
UA (1) UA112652C2 (en)
WO (1) WO2013002578A2 (en)
ZA (1) ZA201400653B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105899193A (en) * 2013-12-31 2016-08-24 西梯茜生命工学股份有限公司 Hot melt fragmentation extruder and process
EP3646871A1 (en) * 2018-10-30 2020-05-06 SEROJAC PME Handels GmbH Treatment and prevention of premature ejaculation (pe)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403597B1 (en) * 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US6495154B1 (en) * 2000-11-21 2002-12-17 Vivus Inc. On demand administration of clomipramine and salts thereof to treat premature ejaculation
US20030229001A1 (en) * 2002-01-31 2003-12-11 Pfizer Inc. Treatment of male sexual dysfunction
JP2007505831A (en) * 2003-09-15 2007-03-15 ベクトゥラ・リミテッド Pharmaceutical composition for treating premature ejaculation by pulmonary inhalation
EP1896076A2 (en) * 2005-06-27 2008-03-12 Daniel Drai Compositions and methods for enhancement of sexual function
US20070166344A1 (en) 2006-01-18 2007-07-19 Xin Qu Non-leaching surface-active film compositions for microbial adhesion prevention
EP2243360A4 (en) 2008-02-20 2011-06-01 Daiwabo Holdings Co Ltd Antiviral substance, antiviral fiber, and antiviral fiber structure
RU2010151969A (en) * 2008-05-19 2012-06-27 Юхан Корпорейшн (Kr) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PREMATURE EJACULATION
KR20110062620A (en) 2009-12-03 2011-06-10 유비벨록스(주) Financial cooperation services offer system using electronic wallet apparatus and financial cooperation services offer method thereby

Also Published As

Publication number Publication date
EA201490173A1 (en) 2014-04-30
EA029932B1 (en) 2018-05-31
JP6042886B2 (en) 2016-12-14
IL230174A (en) 2017-07-31
US20190224208A1 (en) 2019-07-25
HK1193050A1 (en) 2014-09-12
UA112652C2 (en) 2016-10-10
EP3323416A1 (en) 2018-05-23
ZA201400653B (en) 2016-11-30
MX367663B (en) 2019-08-30
KR101978459B1 (en) 2019-05-14
BR112013033475A2 (en) 2017-12-19
MY167609A (en) 2018-09-20
WO2013002578A3 (en) 2013-04-11
CA2840521A1 (en) 2013-01-03
CN103635194A (en) 2014-03-12
EP2727595B1 (en) 2018-02-21
KR20140043898A (en) 2014-04-11
EP2727595A2 (en) 2014-05-07
ES2668943T3 (en) 2018-05-23
AU2012276476B2 (en) 2017-06-29
AU2012276476A1 (en) 2014-02-13
EP3323416B1 (en) 2020-04-22
MA35610B1 (en) 2014-11-01
CN103635194B (en) 2016-02-10
WO2013002578A2 (en) 2013-01-03
TN2013000526A1 (en) 2015-03-30
MX2014000082A (en) 2014-05-01
JP2014527513A (en) 2014-10-16
CA2840521C (en) 2019-11-26
EP2727595A4 (en) 2015-03-04
US20140200210A1 (en) 2014-07-17

Similar Documents

Publication Publication Date Title
HK1201475A1 (en) Methods and compositions for treating pain
EP2684167A4 (en) Compositions and methods useful for treating diseases
PL2672966T3 (en) Pharmaceutical composition, methods for treating and uses thereof
ZA201305783B (en) Composition and methods for treating cardiovascular diseases
HK1190610A1 (en) Pharmaceutical composition for relieving fatigue and preparation method therefor
EP2890391A4 (en) Method and composition for treating hyperglycemia
PL2729151T3 (en) Pharmaceutical composition, methods for treating and uses thereof
EP2701742A4 (en) Compositions and method for treating autoimmune diseases
EP2771030A4 (en) Compositions and methods for treatment of proteinopathies
GB201122195D0 (en) Composition and method
GB201408236D0 (en) Composition and method
EP2666469A4 (en) Pharmaceutical composition for treating melasma and preparation method therefor
EP2766009A4 (en) Method and compositions for treating skin
EP2736437A4 (en) Method and composition for hyperthermally treating cells
HK1259004A1 (en) Composition and method for treatment of diabetes
EP2709614A4 (en) Pharmaceutical compositions and methods for treating cancer
ZA201303222B (en) Composition and method for treating skin conditions
IL231505A0 (en) Pharmaceutical composition and method of preparing same
HK1243637A1 (en) Homeopathic therapeutic method and compositions
SG11201400976WA (en) Methods and pharmaceutical compositions for treating cancer
GB201106433D0 (en) Composition and method
HK1188566A1 (en) Composition and method for treating cancer
EP2566478A4 (en) Pharmaceutical composition and method for treating hypertension
HK1193050A1 (en) Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation
IL231798A0 (en) Method and composition